Clinical Challenges with Iron Chelation in Beta Thalassemia.

Hematol Oncol Clin North Am

Division of Hematology, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, 3501 Civic Center Boulevard, Clinical Hub Building, Room 13547, Philadelphia, PA 19104, USA. Electronic address:

Published: April 2023

Conventional therapy for severe thalassemia includes regular red cell transfusions and iron chelation therapy to prevent and treat complications of iron overload. Iron chelation is very effective when appropriately used, but inadequate iron chelation therapy continues to contribute to preventable morbidity and mortality in transfusion-dependent thalassemia. Factors that contribute to suboptimal iron chelation include poor adherence, variable pharmacokinetics, chelator adverse effects, and difficulties with precise monitoring of response. The regular assessment of adherence, adverse effects, and iron burden with appropriate treatment adjustments is necessary to optimize patient outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2022.12.013DOI Listing

Publication Analysis

Top Keywords

iron chelation
20
chelation therapy
8
adverse effects
8
iron
7
chelation
5
clinical challenges
4
challenges iron
4
chelation beta
4
beta thalassemia
4
thalassemia conventional
4

Similar Publications

Background: Our study aimed to determine the prevalence of Peripheral Neuropathy (using nerve conduction studies (NCS)) in children with transfusion-dependent thalassemia aged between 5 to 18 years and to study its correlation with chronic anemia, ferritin levels, chelation status, annual transfusion requirement, deficiency of serum Vitamin B12, and Folate levels.

Methods: In this hospital-based cross-sectional study, 100 eligible children were enrolled in a tertiary care teaching hospital in New Delhi, India. Neurological examinations focusing on peripheral neuropathy followed by NCS were performed on all the patients.

View Article and Find Full Text PDF

This study investigates the antioxidant, antimicrobial, and anticancer properties of Pancratium maritimum L. in Sp. Pl.

View Article and Find Full Text PDF

Atomically dispersed rare earth dysprosium-nitrogen-carbon for boosting oxygen reduction reaction.

J Colloid Interface Sci

January 2025

Collaborative Innovation Center of Sustainable Energy Materials, School of Physical Science and Technology, Guangxi University, Guangxi Key Laboratory of Electrochemical Energy Materials, State Key Laboratory of Featured Metal Materials and Life-cycle Safety for Composite Structures, Nanning 530004, China. Electronic address:

Transition metal-nitrogen-carbon (MNC) based on 3d metal atoms as promising non-precious metal catalysts have been extensively exploited for oxygen reduction reaction (ORR), but MNC with 4f rare earth metals have been largely ignored, most likely due to their large atomic radii that are difficult to coordinate with N dopants using conventional precursors. Herein, atomically dispersed dysprosium-nitrogen-carbon (DyNC) nanosheets were developed via the pyrolysis of anitrogen-containing chelate compound of 2, 4, 6-Tri (2-pyridyl) 1, 3, 5-triazine (TPTZ) ligand with Dy under the assistance of molten NaCl. The as-synthesized DyNC features specific moieties of single Dy atom coordinated by N and O as active sites for ORR, displaying excellent performance.

View Article and Find Full Text PDF

Imaging abnormal copper/iron with effective fluorescent tools is essential to comprehensively put insight into many pathological events. However, conventional coordination-based detection is mired in the fluorescence quenching induced by paramagnetic Cu(II)/Fe(III). Moreover, the strong chelating property of the probe will consume dissociative metal ions and inevitably interfere with the physiological microenvironment.

View Article and Find Full Text PDF

Background: Iron is implicated in Alzheimer's disease (AD) and is bound to β-amyloid (Ab) plaques. AD brains have increased 4-hydroxynonenal (HNE) adducts, a lipid decomposition product bound to proteins originating from iron mediated lipid peroxidation. Increased brain iron may result from cerebral microbleeds which by nature are rich sources of iron.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!